HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21281401

Download in:

View as

General Info

PMID
21281401